Intrinsic LifeSciences is awarded an NIH SBIR Phase 2 grant Print E-mail

NIDDK SBIR grant totals ~$1.3 million for two years.

Focused on production of monoclonal antibodies to hepcidin for the development of a sensitive diagnostic assay.
Last Updated on Saturday, 10 September 2011 09:04